Skip to content
Screener

Doximity DOCS Financing Cash Flow

Financing Cash Flow at other companies

Microsoft logo
MicrosoftMSFT
-$11.78B-8.6%
Ziff Davis logo
Ziff DavisZD
-$120.29M-277%
AMN Healthcare logo
AMN HealthcareAMN
-$2.37M+97.1%
Veeva Systems logo
Veeva SystemsVEEV
-$262.53M-1,388%
OptimizeRx logo
OptimizeRxOPRX
-$2.71M-361%
Teladoc Health logo
Teladoc HealthTDOC
-$2.45M-418%

Other financials

Income statement

See full
Revenue$156.6M+7.3%
Gross profit$132.9M+2.2%
Operating income$33.6M-38.3%
Net income$24.3M-54.4%
EPS (diluted)$0.13-51.9%

Balance sheet

See full
Cash & equivalents$273.6M+99.3%
Total debt$9.7M-18.3%
Total equity$916.1M-10.7%
Total assets$1.1B-10.0%

Cash flow

See full
Operating cash flow$42.0M-32.4%
CapEx$62.0K
Free cash flow$41.9M-32.5%

Valuation

See full
Market cap$3.77B-65.4%
Enterprise value$3.5B-67.5%
P/E22.6×-23.8×
P/S5.8×-12.7×

Profitability

See full
Gross margin88.1%-2.1pp
Operating margin29.6%-10.5pp
Net margin25.5%-14.4pp
FCF margin49.9%+15.8pp

Returns & leverage

See full
Return on equity17.2%-7.0pp
Debt / equity0.0×
Current ratio6.1×-0.4×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Doximity’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:12 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001516513-26-000040
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Taxes paid related to net share settlement of equity awards(6,974)(11,927)
Repurchase of common stock(91,633)(122,355)
Payment of contingent consideration related to a business combination(5,024)(5,249)
Net cash used in financing activities(100,551)(137,133)
Net increase (decrease) in cash and cash equivalents54,426(72,353)
Cash and cash equivalents, beginning of period219,178209,614
Cash and cash equivalents, end of period$273,604$137,261
Supplemental disclosures of cash flow information

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Doximity's financing cash flow?
Doximity (DOCS) reported financing cash flow of -$100.55M in Q2 2026.
How has Doximity's financing cash flow changed year-over-year?
Doximity's financing cash flow increased by 26.7% year-over-year, from -$137.13M to -$100.55M.
What is the long-term trend for Doximity's financing cash flow?
Over 4 years (2022 to 2026), Doximity's financing cash flow has grown at a -4.6% compound annual growth rate (CAGR), from $560.42M to -$464.06M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Doximity's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude